Answers are grounded in this paper and cite their sources.
Purpose: Multiparametric magnetic resonance imaging and PIRADS scores transformed prostate cancer diagnostics by enabling targeted biopsy. Within each PI-RADS category, apparent diffusion coefficient (ADC) values vary considerably. We hypothesized that ADC thresholds could serve as an additional predictor to identify patients likely to benefit from the addition of random biopsies to MRI-targeted sampling. Methods Trans-perineal biopsy database of MRI targeted biopsies and systematic biopsies yielded 306 biopsy sessions. ADC values, PI-RADS score, and pathological results were obtained. Lesions were stratified by PI-RADS category (3–5) and ADC threshold (<750 vs ≥750×10⁻⁶ mm²/s). Detection rates between targeted and Systematic biopsies were compared using McNemar tests. Results: Among 306 men, cancer was detected by targeted biopsy alone in 163 cases (53.2%) and by Systematic biopsy in 175 cases (57.2%) (p=0.001). When stratified based on PIRADS score, the benefit of adding random biopsy was shown in PIRADS 4 lesions, with an increased detection by 5.7% (p = 0.004). No statistically significant difference was observed in PIRADS 3 or 5 lesions (p=0.5 and 1.000). Within PIRADS 4 lesions, there was a 6.7% increase in cancer detection in high ADC (≥ 750) lesions (TB: 38.84% vs SB: 45.45%) (p=0.016). However, in low ADC (<750) lesions, SB did not significantly contribute to prostate cancer detection (TB: 73.0% vs SB: 75.68%) (p=1.000) Conclusion: ADC values above 750×10⁻⁶mm²/s identified PI-RADS 4 patients benefit from random biopsies. Overall, random biopsy cores remain valuable in PI-RADS 4 lesions, and ADC stratification could guide biopsy decisions in selected patients.
No takes yet. Share an insight, caveat, or question.
Nasrallah et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: